Ignite Creation Date:
2024-05-06 @ 6:11 PM
Last Modification Date:
2024-10-26 @ 2:43 PM
Study NCT ID:
NCT05577442
Status:
UNKNOWN
Last Update Posted:
2022-10-19
First Post:
2022-10-09
Brief Title:
Trastuzumab Pyrotinib Combined With Dalpiciclib and Endocrine Therapy for HR HER2 Advanced Breast Cancer
Sponsor:
Organization:
Peking University Cancer Hospital Institute